NASDAQ$HOLX

Hologic Inc · Q3 2021 earnings

Q3 2021 earnings · · Investor relations

Briefing

Hologic's financial results for Q3 2021 were announced, with revenue increasing by 42.0% and GAAP diluted EPS reported at $1.04.

Hologic reported strong financial results for the third quarter of fiscal year 2021, with revenue increasing 42.0% to $1.168 billion and GAAP diluted EPS reaching $1.04. The company finalized the Mobidiag acquisition and experienced growth in its base businesses.

  • Revenue increased 42.0% for the quarter, or 37.8% in constant currency.
  • Organic revenue in the third quarter increased 38.4%, or 34.2% in constant currency, excluding material acquisitions and divestitures.
  • Worldwide diagnostics revenue increased 25.0%, despite lower demand for COVID assays.
  • The company completed the acquisition of Mobidiag for approximately $808 million.

Headline financials

Total Revenue

$1.17B

Previous: $823M+42.0%
EPS (adj)

$1.33

Previous: $0.75+77.3%
Capital Expenditures

-$71.2M

Previous: -$53.2M-33.8%
Free Cash Flow

$1.79B

Previous: $401M+346.9%
Net Income

$268M

Previous: $136M+96.6%
Operating Income

$359M

Previous: $191M+87.7%
Gross Profit

$702M

Previous: $466M+50.5%
Cash & Equivalents

$828M

Previous: $744M+11.2%
Total Assets

$8.59B

Previous: $6.8B+26.3%
Stock-Based Comp

$15.4M

Previous: $19.9M-22.6%

Revenue & EPS history

Hologic · Revenue · Quarterly

$1.17B

Q3 2021+42%vs Q3 2020
Beat estimate in 15 of 16 quarters(94%)
ActualEstimate

Revenue by segment

Hologic · $1.55B total across 3 segments · Q3 2021

  • Diagnostics
    $666M+25.0%
  • Molecular Diagnostics
    $536M+16.5%
  • Breast Health
    $349M+55.8%

Forward guidance

For Q4 2021, Hologic anticipates strong growth in base businesses, which will be offset by declines in COVID testing revenue.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2021

Historical avgQ3 2021

-0.5%

Avg return

Earnings day

+0.2%

Avg return

5 days after

-0.1%

Avg return

30 days after

49%

35 / 72 earnings

Positive

+12.3%

Q3 2020

Best reaction

-11.4%

Q2 2012

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2026
Q1 2026+0.0%-0.6%+0.7%
Q4 2025+0.1%+0.1%+0.9%
Q3 2025+2.8%+4.4%+3.3%
Q2 2025-5.6%-3.2%+8.5%
Q1 2025-10.1%-11.4%-11.3%
Q4 2024-4.3%-4.3%-6.6%
Q3 2024+4.9%+6.4%+2.2%
Q2 2024+0.3%-0.2%-3.3%
Q1 2024-2.7%-0.4%-1.1%
Q4 2023+5.7%+5.4%+0.1%
Q3 2023-5.1%-5.9%-5.4%
Q2 2023-2.4%-2.6%-8.3%
Q1 2023+3.8%+3.6%-1.1%
Q4 2022+10.8%+12.4%+13.8%
Q3 2022+1.0%+1.3%-3.4%
Q2 2022+1.2%+3.4%+9.8%
Q1 2022+4.0%+3.8%+2.4%
Q4 2021-3.3%-5.9%-0.3%
Q3 2021+2.3%+5.0%+9.7%
Q2 2021-9.1%-9.9%-13.4%
Q1 2021+1.7%+11.2%-3.3%
Q4 2020+6.6%-5.0%+1.7%
Q3 2020+12.3%+14.8%-2.8%
Q2 2020+2.9%+2.6%+8.9%
Q1 2020-0.7%-1.8%-13.7%
Q4 2019-4.0%+8.8%+10.3%
Q3 2019-1.3%-6.5%-4.1%
Q2 2019-0.1%+0.7%-5.1%
Q1 2019+0.6%-0.5%+8.6%
Q4 2018+4.9%+1.2%+3.7%
Q3 2018-3.5%-1.9%-7.5%
Q2 2018-6.9%-6.8%-3.9%
Q1 2018-6.7%-6.6%-2.2%
Q4 2017+0.4%+2.9%+8.1%
Q3 2017-9.3%-11.3%-12.5%
Q2 2017-4.3%-5.1%-2.0%
Q1 2017-2.6%-2.9%+1.8%
Q4 2016+4.3%+8.5%+6.3%
Q3 2016+3.9%+5.8%+5.3%
Q2 2016-10.0%
Q1 2016-9.2%
Q4 2015+0.6%
Q3 2015+8.6%
Q2 2015+2.1%
Q1 2015+5.1%
Q4 2014-1.7%
Q3 2014+2.1%
Q2 2014+8.1%
Q1 2014-5.9%
Q4 2013-6.9%
Q3 2013-0.2%
Q2 2013+0.1%
Q1 2013-4.1%
Q4 2012-0.3%
Q3 2012-0.4%
Q2 2012-11.4%
Q1 2012+5.2%
Q4 2011-4.0%
Q3 2011-3.9%
Q2 2011-0.6%
Q1 2011+0.0%
Q4 2010+1.2%
Q3 2010+1.2%
Q2 2010-2.6%
Q1 2009-2.8%
Q1 2010-1.1%
Q2 2009+2.9%
Q4 2007+2.9%
Q4 2009+2.9%
Q3 2009-3.0%
Q3 2008-3.0%
Q4 2008-3.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro